Creo Historical Balance Sheet

CREO Stock

14.63 0.25 1.68%

Trend analysis of Creo Medical Group balance sheet accounts such as Other Current Liab of 2.7 M, Total Current Liabilities of 12 M or Accounts Payable of 3 M provides information on Creo Medical's total assets, liabilities, and equity, which is the actual value of Creo Medical Group to its prevalent stockholders. By breaking down trends over time using Creo Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Creo Medical Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Creo Medical Group is a good buy for the upcoming year.

Creo Medical Inventory

9.78 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creo Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Creo Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Creo Medical Group at a specified time, usually calculated after every quarter, six months, or one year. Creo Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Creo Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Creo currently owns. An asset can also be divided into two categories, current and non-current.

Creo Medical Balance Sheet Chart

At this time, Creo Medical's Total Stockholder Equity is comparatively stable compared to the past year. Inventory is likely to gain to about 9.8 M in 2025, whereas Cash is likely to drop slightly above 3.3 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Accounts Payable Short Term Investments Cash And Short Term Investments

Add Fundamental

Total Assets

Total assets refers to the total amount of Creo Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Creo Medical Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Creo Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Creo Medical Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Creo Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Creo Medical Group are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Investments

Short Term Investments is an item under the current assets section of Creo Medical balance sheet. It contains any investments Creo Medical Group undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Creo Medical Group can easily liquidate in the marketplace.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Creo Medical Group balance sheet. This account contains Creo Medical investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Creo Medical Group fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Creo Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Creo Medical Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creo Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	7.5M	3.8M	4.4M	2.7M
Total Assets	75.3M	76.6M	88.1M	92.5M

Other Current Liab Total Assets

Creo Medical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Accounts Payable	Short Term Investments	Total Liab	Property Plant Equipment	Other Liab	Cash	Net Receivables	Total Stockholder Equity	Retained Earnings	Inventory	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.82	0.88	0.82	0.5	0.87	0.81	0.96	0.57	0.89	0.99	-0.81	0.86	0.8	-0.3	0.84	-0.55	0.65	0.89	0.73	0.83	0.86	0.91	0.75	0.89	0.78
Other Current Liab	0.82		0.96	0.83	0.11	0.94	0.67	0.71	0.48	0.58	0.73	-0.62	0.79	0.66	-0.22	0.77	-0.89	0.46	0.66	0.43	0.86	0.73	0.63	0.57	0.7	0.43
Total Current Liabilities	0.88	0.96		0.92	0.33	0.99	0.82	0.8	0.34	0.73	0.78	-0.77	0.92	0.82	-0.07	0.9	-0.81	0.38	0.74	0.62	0.94	0.79	0.78	0.75	0.66	0.61
Accounts Payable	0.82	0.83	0.92		0.46	0.92	0.9	0.78	0.17	0.82	0.74	-0.87	0.94	0.91	-0.01	0.92	-0.67	0.35	0.83	0.71	0.88	0.89	0.84	0.86	0.55	0.72
Short Term Investments	0.5	0.11	0.33	0.46		0.4	0.75	0.56	-0.27	0.79	0.5	-0.79	0.66	0.73	0.4	0.68	0.27	0.0	0.52	0.94	0.52	0.42	0.78	0.8	0.19	0.92
Total Liab	0.87	0.94	0.99	0.92	0.4		0.84	0.8	0.27	0.76	0.78	-0.81	0.94	0.84	-0.01	0.93	-0.77	0.34	0.74	0.68	0.98	0.77	0.81	0.77	0.63	0.66
Property Plant Equipment	0.81	0.67	0.82	0.9	0.75	0.84		0.81	0.01	0.9	0.75	-0.97	0.97	1.0	0.23	0.97	-0.39	0.18	0.75	0.91	0.85	0.8	0.95	0.99	0.48	0.89
Other Liab	0.96	0.71	0.8	0.78	0.56	0.8	0.81		0.51	0.91	0.96	-0.82	0.84	0.8	-0.23	0.82	-0.45	0.59	0.88	0.77	0.79	0.85	0.93	0.77	0.85	0.81
Cash	0.57	0.48	0.34	0.17	-0.27	0.27	0.01	0.51		0.22	0.63	-0.02	0.09	-0.01	-0.89	0.04	-0.42	0.88	0.46	-0.09	0.15	0.42	0.21	-0.09	0.86	0.03
Net Receivables	0.89	0.58	0.73	0.82	0.79	0.76	0.9	0.91	0.22		0.88	-0.94	0.89	0.89	-0.03	0.88	-0.25	0.45	0.9	0.92	0.79	0.84	0.98	0.89	0.66	0.96
Total Stockholder Equity	0.99	0.73	0.78	0.74	0.5	0.78	0.75	0.96	0.63	0.88		-0.77	0.78	0.74	-0.38	0.76	-0.44	0.72	0.88	0.71	0.73	0.84	0.89	0.7	0.93	0.77
Retained Earnings	-0.81	-0.62	-0.77	-0.87	-0.79	-0.81	-0.97	-0.82	-0.02	-0.94	-0.77		-0.95	-0.97	-0.18	-0.94	0.31	-0.23	-0.79	-0.93	-0.83	-0.83	-0.96	-0.97	-0.51	-0.93
Inventory	0.86	0.79	0.92	0.94	0.66	0.94	0.97	0.84	0.09	0.89	0.78	-0.95		0.97	0.16	1.0	-0.54	0.24	0.78	0.87	0.94	0.81	0.93	0.94	0.55	0.85
Property Plant And Equipment Net	0.8	0.66	0.82	0.91	0.73	0.84	1.0	0.8	-0.01	0.89	0.74	-0.97	0.97		0.24	0.97	-0.4	0.16	0.74	0.9	0.84	0.8	0.94	0.99	0.46	0.88
Net Debt	-0.3	-0.22	-0.07	-0.01	0.4	-0.01	0.23	-0.23	-0.89	-0.03	-0.38	-0.18	0.16	0.24		0.22	0.23	-0.9	-0.37	0.29	0.12	-0.3	0.04	0.3	-0.65	0.16
Non Current Assets Total	0.84	0.77	0.9	0.92	0.68	0.93	0.97	0.82	0.04	0.88	0.76	-0.94	1.0	0.97	0.22		-0.52	0.19	0.75	0.88	0.95	0.77	0.92	0.94	0.51	0.85
Non Currrent Assets Other	-0.55	-0.89	-0.81	-0.67	0.27	-0.77	-0.39	-0.45	-0.42	-0.25	-0.44	0.31	-0.54	-0.4	0.23	-0.52		-0.3	-0.4	-0.07	-0.66	-0.52	-0.31	-0.29	-0.48	-0.05
Cash And Short Term Investments	0.65	0.46	0.38	0.35	0.0	0.34	0.18	0.59	0.88	0.45	0.72	-0.23	0.24	0.16	-0.9	0.19	-0.3		0.71	0.15	0.25	0.59	0.38	0.11	0.86	0.28
Common Stock Total Equity	0.89	0.66	0.74	0.83	0.52	0.74	0.75	0.88	0.46	0.9	0.88	-0.79	0.78	0.74	-0.37	0.75	-0.4	0.71		0.69	0.72	0.92	0.85	0.71	0.78	0.79
Common Stock Shares Outstanding	0.73	0.43	0.62	0.71	0.94	0.68	0.91	0.77	-0.09	0.92	0.71	-0.93	0.87	0.9	0.29	0.88	-0.07	0.15	0.69		0.75	0.64	0.93	0.93	0.41	0.98
Non Current Liabilities Total	0.83	0.86	0.94	0.88	0.52	0.98	0.85	0.79	0.15	0.79	0.73	-0.83	0.94	0.84	0.12	0.95	-0.66	0.25	0.72	0.75		0.7	0.82	0.79	0.55	0.73
Other Current Assets	0.86	0.73	0.79	0.89	0.42	0.77	0.8	0.85	0.42	0.84	0.84	-0.83	0.81	0.8	-0.3	0.77	-0.52	0.59	0.92	0.64	0.7		0.83	0.76	0.75	0.71
Other Stockholder Equity	0.91	0.63	0.78	0.84	0.78	0.81	0.95	0.93	0.21	0.98	0.89	-0.96	0.93	0.94	0.04	0.92	-0.31	0.38	0.85	0.93	0.82	0.83		0.94	0.66	0.95
Property Plant And Equipment Gross	0.75	0.57	0.75	0.86	0.8	0.77	0.99	0.77	-0.09	0.89	0.7	-0.97	0.94	0.99	0.3	0.94	-0.29	0.11	0.71	0.93	0.79	0.76	0.94		0.4	0.91
Total Current Assets	0.89	0.7	0.66	0.55	0.19	0.63	0.48	0.85	0.86	0.66	0.93	-0.51	0.55	0.46	-0.65	0.51	-0.48	0.86	0.78	0.41	0.55	0.75	0.66	0.4		0.5
Common Stock	0.78	0.43	0.61	0.72	0.92	0.66	0.89	0.81	0.03	0.96	0.77	-0.93	0.85	0.88	0.16	0.85	-0.05	0.28	0.79	0.98	0.73	0.71	0.95	0.91	0.5

Click cells to compare fundamentals

Creo Medical Account Relationship Matchups

Creo Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	92.5M	100.6M	75.3M	76.6M	88.1M	92.5M
Other Current Liab	9.4M	10.3M	7.5M	3.8M	4.4M	2.7M
Total Current Liabilities	18.0M	19.7M	17.5M	9.9M	11.4M	12.0M
Accounts Payable	2.5M	3.5M	4.3M	2.5M	2.9M	3.0M
Total Liab	29.7M	27.3M	25.9M	16.8M	19.3M	20.3M
Property Plant Equipment	906.3K	1.3M	3.4M	8.6M	9.9M	10.4M
Cash	45.1M	43.5M	13.1M	3M	3.5M	3.3M
Net Receivables	4.2M	3.9M	5M	6.4M	7.4M	7.7M
Total Stockholder Equity	62.8M	73.3M	49.4M	59.8M	68.8M	72.2M
Retained Earnings	(57.6M)	(82.2M)	(109.1M)	(144.4M)	(130.0M)	(123.5M)
Inventory	6.8M	8.5M	9.3M	8.1M	9.3M	9.8M
Property Plant And Equipment Net	3.4M	8.6M	10.2M	9.1M	10.5M	11.0M
Net Debt	(32.7M)	(33.0M)	(3.0M)	5.3M	4.8M	5.0M
Non Current Assets Total	33.0M	39.4M	41.7M	38.7M	44.5M	46.7M
Non Currrent Assets Other	(18.3M)	(18.6M)	(19.6M)	200K	180K	189K
Cash And Short Term Investments	45.1M	43.5M	13.1M	18.5M	21.3M	26.4M
Common Stock Shares Outstanding	161.6M	170.4M	187.9M	313.0M	360.0M	378.0M
Liabilities And Stockholders Equity	92.5M	100.6M	75.3M	76.6M	88.1M	55.6M
Non Current Liabilities Total	11.6M	7.6M	8.5M	6.9M	7.9M	8.3M
Other Current Assets	3.3M	5.3M	6.3M	4.9M	5.6M	3.5M
Other Stockholder Equity	101.7M	135.8M	149.5M	180.9M	208.0M	218.4M
Property Plant And Equipment Gross	3.4M	13.6M	17.0M	17.3M	19.9M	20.9M
Total Current Assets	59.5M	61.2M	33.7M	37.9M	43.6M	32.9M
Accumulated Other Comprehensive Income	4.9M	5.8M	8.8M	22.9M	26.3M	27.7M
Common Stock	158K	181K	182K	400K	460K	483K
Net Tangible Assets	47.4M	81.9M	34.8M	46.4M	53.4M	29.1M
Other Assets	19.3K	128.4K	1.1M	1.0	1.15	1.09
Short Long Term Debt Total	12.4M	10.6M	10.1M	8.3M	9.5M	5.2M
Long Term Debt	5.2M	3.8M	4.9M	4.4M	5.1M	5.3M
Short Long Term Debt	5.2M	4.7M	1.6M	2.5M	2.9M	1.6M
Short Term Debt	5.8M	5.4M	4.6M	3.1M	3.6M	2.2M
Intangible Assets	28.5M	27.3M	27.6M	7.1M	8.2M	10.1M
Current Deferred Revenue	(4.0M)	161K	214K	(200K)	(230K)	(241.5K)
Capital Lease Obligations	2.0M	2.1M	1.7M	1.4M	1.6M	1.4M
Net Invested Capital	73.2M	81.8M	51.0M	66.7M	76.7M	67.9M
Net Working Capital	38.7M	41.4M	16.2M	28M	25.2M	29.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Creo Stock Analysis

When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC